Full-Field Digital Mammography Linked to Lower Recall, Biopsy Rates

Share this content:
Full-Field Digital Mammography Linked to Lower Recall, Biopsy Rates
Full-Field Digital Mammography Linked to Lower Recall, Biopsy Rates

(HealthDay News) — Compared with screen-film mammography (SFM), full-field digital mammography (FFDM) is associated with reduced recall and biopsy rates, according to research published online April 1 in Radiology.

Solveig Hofvind, PhD, of the Oslo and Akershus University College of Applied Sciences in Norway, and colleagues compared performance measures for the transition from SFM to FFDM in a population-based screening program for women aged 50 to 69 years.

RELATED: Breast Cancer Resource Center

The researchers found that FFDM was associated with a significantly lower recall rate (2.9% vs 3.4%) and biopsy rate (1.1% vs 1.4%) than SFM (P < 0.001 for both). FFDM also was associated with significant (P < 0.001 for both) increases in positive predictive values for recall examinations (from 19.3% to 22.7%) and invasive procedures (from 48.3% to 57.5%).

Compared with SFM, the rate of screening-detected ductal carcinoma in situ was significantly higher, and the rate of screening-detected invasive breast cancer was significantly lower, with FFDM.

"After the initial transitional phase from SFM to FFDM, population-based screening with FFDM is associated with less harm because of lower recall and biopsy rates and higher positive predictive values after biopsy than screening with SFM," the researchers wrote.

One author disclosed financial ties to medical publishing and biomedical companies.

Reference

  1. Hofvind S, Skaane P, Elmore JG, et al. Mammographic Performance in a Population-based Screening Program: Before, during, and after the Transition from Screen-Film to Full-Field Digital Mammography. Radiology. 2014; doi:10.1148/radiol.14131502.

Related Resources

Related Slideshows

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs